Scancell Holdings Revenue

Revenue

n/a

Revenue Growth

n/a

P/S Ratio

n/a

Revenue / Employee

n/a

Employees

Market Cap

141.70M USD

Revenue Chart

* This company reports financials in GBP.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Apr 30, 2024	-	-	-
Apr 30, 2023	5.27M	-	-
Apr 30, 2022	-	-	-
Apr 30, 2021	-	-	-
Apr 30, 2020	-	-	-
Apr 30, 2019	Pro	Pro	Pro
Apr 30, 2018	Pro	Pro	Pro
Apr 30, 2017	Pro	Pro	Pro
Apr 30, 2016	Pro	Pro	Pro
Apr 30, 2015	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Endo, Inc.	1.73B
Veradigm	588.02M
Tian'an Technology Group	1.78M
Elite Pharmaceuticals	84.04M
Glass House Brands	215.62M
American Oncology Network	1.76B
Northwest Biotherapeutics	1.47M
Silence Therapeutics	27.70M

Revenue Rankings

Scancell Holdings News

10 months ago - PharmaJet and Scancell Sign Strategic Partnership Agreement for Development and Commercialization of a Needle-free DNA Vaccine for Advanced Melanoma - Business Wire
1 year ago - PharmaJet Partner, Scancell, Announces Positive Data from the First Stage of its Phase 2 Trial of Advanced Melanoma DNA Vaccine delivered Needle-free - Business Wire

More News